Ocumension Therapeutics (1477.HK)
HKD 5.45
(8.57%)
HKD 5.45
(8.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.27 Billion CNY | 7.47% |
| 2022 | 3.04 Billion CNY | -8.63% |
| 2021 | 3.33 Billion CNY | 28.14% |
| 2020 | 2.59 Billion CNY | 101.56% |
| 2019 | 1.28 Billion CNY | 1263.0% |
| 2018 | 94.62 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 3 Billion CNY | -1.4% |
| 2023 Q4 | 3.27 Billion CNY | 0.0% |
| 2023 Q2 | 3 Billion CNY | 0.0% |
| 2023 Q3 | 3.27 Billion CNY | 9.0% |
| 2023 FY | 3.27 Billion CNY | 7.47% |
| 2022 Q1 | 3.26 Billion CNY | -1.91% |
| 2022 Q4 | 3.04 Billion CNY | 0.0% |
| 2022 Q3 | 3.04 Billion CNY | -6.85% |
| 2022 Q2 | 3.26 Billion CNY | 0.0% |
| 2022 FY | 3.04 Billion CNY | -8.63% |
| 2021 Q1 | 3.28 Billion CNY | 26.18% |
| 2021 FY | 3.33 Billion CNY | 28.14% |
| 2021 Q3 | 3.33 Billion CNY | 1.55% |
| 2021 Q2 | 3.28 Billion CNY | 0.0% |
| 2021 Q4 | 3.33 Billion CNY | 0.0% |
| 2020 Q3 | 2.59 Billion CNY | 108.69% |
| 2020 Q4 | 2.59 Billion CNY | 0.0% |
| 2020 FY | 2.59 Billion CNY | 101.56% |
| 2020 Q1 | 1.24 Billion CNY | -3.41% |
| 2020 Q2 | 1.24 Billion CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 1.28 Billion CNY | 0.0% |
| 2019 Q3 | 1.28 Billion CNY | 0.0% |
| 2019 FY | 1.28 Billion CNY | 1263.0% |
| 2018 FY | 94.62 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -697.82% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 70.918% |